ON
ONSS.US Onassis Holdings Corp
- Market cap
- USD 25.6K
- P/E
- -
- P/B
- 0.01x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2024.
Is ONSS.US undervalued?
Graham numberThe Graham number of Onassis Holdings Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Onassis Holdings Corp fundamental analysis
No fundamental analysis for Onassis Holdings Corp yet.
Onassis Holdings Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Onassis Holdings Corp
Onassis Holdings Corp. focuses on marketing and distributing nutraceutical products and the licensing and commercialization of anti-aging technology. It offers products in therapeutic area, such as skin, hair, and immune system. The company was formerly known as Onassis Mining Group, Inc. and changed its name to Onassis Holdings Corp. in September 2019. Onassis Holdings Corp. is based in New York, New York.
Full company profileOnassis Holdings Corp financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Onassis Holdings Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 8.26M | 12.2M | 14.8M | 15.9M | 18.4M | - | 44.4K | 53.4K | 6.78K | - | - |
| Gross Profit | 1.31M | 3.53M | 6.43M | 6.79M | 7.16M | - | - | 53.4K | 6.78K | - | - |
| Operating Income | 344K | 1.05M | 2.62M | 2.21M | 2.37M | -100K | -160K | -396K | -161K | -182K | -866K |
| EBITDA | 417K | 1.68M | 2.68M | 1.48M | 1.82M | -100K | -160K | -159K | 67.5K | -14.1K | -3.92M |
| Net Income | 197K | -539K | 1.38M | 906K | 990K | -97.2K | -300K | -451K | -190K | -216K | -4.86M |
| EPS | 0.24 | -0.48 | 0.85 | 0.06 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 |
| Balance Sheet | |||||||||||
| Total Assets | 23.8M | 28.9M | 19.3M | 18.5M | 18.5M | 106K | 80.7K | 189K | 851K | 864K | 940K |
| Total Liabilities | 11.8M | 17.6M | 7.19M | 5.46M | 7.13M | 103K | 221K | 767K | 919K | 1.15M | 3.34M |
| Shareholders' Equity | 12.0M | 11.3M | 12.1M | 13.0M | 11.3M | 2.69K | -141K | -577K | -67.7K | -284K | -2.40M |
| Cash & Short-term Investments | 102K | 21.5K | 8.81K | 11.3K | 585K | 100.00 | 5.15K | 114K | 74.3K | 2.32K | 41.4K |
| Total Debt | 9.96M | 11.7M | 3.60M | 3.70M | 2.67M | 100K | 210K | 732K | 856K | 1.05M | 1.29M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.97M | 2.44M | 4.56M | -1.63M | 574K | -110K | -161K | -382K | -164K | -268K | -812K |
| Capital Expenditure | 5.12M | 4.88M | 1.98M | 0.00 | 0.00 | 0.00 | 5.00 | 3.00 | 5.00 | 0.00 | 110K |
| Free Cash Flow | -7.08M | -2.44M | 2.58M | -1.63M | 574K | -110K | -161K | -382K | -164K | -268K | -922K |
| Ratios | |||||||||||
| ROE | 1.6% | -4.8% | 11.4% | 7.0% | 8.7% | -3,621.8% | - | - | - | - | - |
| ROA | 0.8% | -1.9% | 7.1% | 4.9% | 5.4% | -92.1% | -372.4% | -238.2% | -22.3% | -25.0% | -516.8% |
| Net Profit Margin | 2.4% | -4.4% | 9.3% | 5.7% | 5.4% | - | -676.1% | -844.6% | -2,804.4% | - | - |
| Debt to Equity | 0.83x | 1.04x | 0.30x | 0.28x | 0.24x | 37.28x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Onassis Holdings Corp dividends
Onassis Holdings Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 1:200 on Feb 9, 2012.
Who owns Onassis Holdings Corp
Ownership data of Onassis Holdings Corp is not available yet.
Onassis Holdings Corp company profile
- Company name
- Onassis Holdings Corp
- Ticker
- ONSS.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- 39 Broadway, New York, NY, United States, 10006
- Phone
- 516 620 6794
- Website
- onassis-holdings.com
About Onassis Holdings Corp
Onassis Holdings Corp. focuses on marketing and distributing nutraceutical products and the licensing and commercialization of anti-aging technology. It offers products in therapeutic area, such as skin, hair, and immune system. The company was formerly known as Onassis Mining Group, Inc. and changed its name to Onassis Holdings Corp. in September 2019. Onassis Holdings Corp. is based in New York, New York.
Onassis Holdings Corp management
4- Mr. Eliron YaronFounder, Chairman of the Board, Principal Executive Officer & CFO
- Prof. Yosef BuganimCo-Founder & CSO
- Dr. Eyal Gottlieb Ph.D.Co-Founder & CTO
- Mr. Roby Reuven ZomerC.O.O · born 1980